Ensign Peak Advisors »

Akero Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 155k 28.69
2024-06-30 $5.6M 238k 23.46
2024-03-31 $5.9M 233k 25.26
2023-09-30 $12M 233k 50.58
2023-06-30 $8.3M 178k 46.69
2023-03-31 $6.7M 176k 38.26
2022-12-31 $8.9M 163k 54.80
2022-09-30 $5.8M 170k 34.05
2022-06-30 $676k 72k 9.46
2022-03-31 $359k 25k 14.20
2021-12-31 $535k 25k 21.16
2021-09-30 $565k 25k 22.35
2021-06-30 $628k 25k 24.84
2021-03-31 $733k 25k 28.99
2020-12-31 $652k 25k 25.79
2020-09-30 $595k 19k 30.80
2020-06-30 $678k 27k 24.92
2020-03-31 $324k 15k 21.22
2019-12-31 $529k 24k 22.21